GSK

Q3FY25: GSK pharma’s profit surges 4X to Rs 229 crore; Revenue up 18 percent

In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company stated.

February 14, 2025 16:42 IST

To defy shrinking lifespan, companies need to stay ahead of the curve and innovate: Deepak Parekh

Statistics show about half a century ago, the average lifespan of a company was 60 years. Today, it has shrunk…

November 12, 2024 18:02 IST

GSK moves mRNA flu vaccine to late-stage trials following positive outcomes

In July, GSK bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, boosting its messenger RNA…

September 12, 2024 15:49 IST

GSK’s COPD drug candidate shows significantly positive outcome in Phase III trial

COPD is the third leading cause of death worldwide with exacerbations accounting for the greatest proportion of the total COPD…

September 9, 2024 17:26 IST

GSK takes full rights to COVID-19, influenza vaccines from CureVac

The partnership began in 2020 during the COVID-19 pandemic and saw the two companies work together to develop vaccines for…

July 5, 2024 10:46 IST

GSK, Aiolos, Asthma drug, experimental drug, healthcare news, pharma news,

GSK presents significantly positive outcomes of its vaccine against Shingles

A variety of factors can increase the risk of developing shingles, including advancing age and immunodeficiency or immunosuppression, as well…

May 15, 2024 17:55 IST

GSK, GSK vaccine, RSV, RSV treatment, healthcare news, pharma news,

GSK’s Arexvy label expansion will intensify competition with Pfizer’s Abrysvo in RSV space

The application is supported by positive trial results from a Phase III, placebo-controlled, observer-blind, randomized, multi-country immunogenicity clinical trial.

February 5, 2024 11:46 IST

GSK to buy Asthma drug owner Aiolos for up to $1.4 billion

Walmsley said Monday that she’s watching for deals that would expand the UK company’s existing pipeline.

January 9, 2024 17:09 IST

GSK, cancer drug Jemperli, chemotherapy, endometrial cancer, gynaecologic cancer, latest healthcare news, latest news,

GSK says endometrial cancer drug meets overall survival goal in late-stage trial

British drugmaker GSK said on Monday its cancer drug Jemperli, when combined with chemotherapy.

October 30, 2023 18:23 IST

Pfizer, Pfizer Q3 results, quarter earnings, profit, revenue, EBITDA, appointment, resignation

Pfizer and GSK’s new RSV vaccines on track For $2 billion in sales

In the US alone, Murphy expects GSK to sell about $1.1 billion of its adult vaccine in 2023, while Pfizer…

October 4, 2023 08:00 IST

European Commission, GSK, RSV vaccine, healthcare news, pharma news,

GSK gets FDA approval for Jemperli use with chemo to treat Endometrial Cancer

GSK has invested heavily in the drug, also known as dostarlimab, and is seeking to eventually show it could be…

August 2, 2023 10:00 IST

GlobalData, biologics drugs, small molecules, venture, healthcare news, pharma news,

After BCG, a new TB vaccine enters the final trial phase; read on to know all about this ‘promising’ shot

Reportedly, this vaccine could save 8.5 million lives and prevent 76m cases of TB, over the next 25 years. The…

June 30, 2023 15:21 IST

European Commission gives final nod to GSK’s RSV vaccine

RSV, a common contagious virus affecting the lungs and breathing passages, usually causes mild, cold-like symptoms but can also lead…

June 7, 2023 14:50 IST

Emcure Pharmaceuticals, iron deficiency, pregnancy, healthcare news, pharma news,

USFDA approves world’s first vaccine against life-threatening respiratory illness

According to a study published by the pharma major in February, the efficacy of this vaccine is at 82.6 percent.

May 5, 2023 12:07 IST

Centrum, Centrum India, Haleon, Haleon India, GSK, gummies market, healthcare news,

Centrum launches specialised nutritious gummies in India

The company claims that the brand is trying to recognise the emerging nutrition gaps Indian consumers face daily due to…

April 13, 2023 11:01 IST

GSK, Pfizer, Sanofi, Zantac, cancer, health news, pharma news,

GSK, Pfizer, Sanofi get relief after court found claims of Zantac-linked cancer not ‘backed by science’

Zantac, first approved in 1983, became the world’s best-selling medicine in 1988 and one of the first-ever drugs to top…

December 7, 2022 15:06 IST

GSK’s blood cancer drug fails main trial goal, shares fall

As oncology is a key area of focus for GSK as a standalone prescription medicine and vaccine business, the company’s…

November 7, 2022 16:04 IST

GSK, otilimab, investigational monoclonal antibody, Rheumatoid Arthritis (RA), Health news, pharma news,

GSK to skip regulatory submissions for its investigational drug

Rheumatoid Arthritis (RA) is a chronic, systemic inflammatory condition characterised by pain, joint swelling, stiffness, joint destruction and disability.

October 27, 2022 15:02 IST

Related News

Four big companies have now stopped sponsoring H-1B visas. Here is the full list

From H-1B to green card: Follow the journey of an Indian entrepreneur to $3.7 billion

Indian techie overcomes H-1B challenges, gets green card, quits job, and achieves $3.7 billion success

EB-5 fees, EB-5 filing fees cut, EB-5 visa, USCIS EB-5 rule, DHS EB-5 rule, Form I-526 fee reduction, Form I-829 petition, EB-5 investor program, EB-5 technology fee, EB-5 program changes

US cuts EB-5 fees for foreign investors seeking employment-based green cards

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar card update new rules from November 2025: You won’t need to upload documents anymore — here’s how to change your details online

UK immigration new rules, Skilled Worker visa changes, Graduate visa months, UK visa reforms, High Potential Individual route, UK student visa rules, UK Visa English requirement

UK announces major changes in immigration rules for overseas students and foreign workers

Jio pivoting from mobile growth to home broadband play: Analysts

Business3 hr ago

Reliance Jio’s Q2 results showed a shift towards home connectivity, with 8.3 million new users and a total of 506 million subscribers. Fixed broadband and 5G net additions were at 2.4 million and 21 million respectively. FWA and FTTH net adds were 2.1 million and 0.9 million, indicating the success of Jio’s home broadband expansion.

View all shorts